SCHEMBL2008432

SCHEMBL2008432

Nc1cccc(C(=O)Nc2c(Cl)cc(SC(F)(F)C(F)(F)C(F)(F)F)cc2Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PTGS1 P23219 5/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4C Q9H3R0 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
TAS1R2 Q8TE23 1/20 0.40
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
ABCC9 O60706 1/20 0.38
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
KCNJ8 Q15842 1/20 0.38
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699014 0.86 PTGS1 (0.47) SMN1; SMN2NPSR1HSD17B10PTGS1KDM4E
SCHEMBL699294 0.83 LMNA (0.51) SMN1; SMN2NPSR1ALDH1A1MEN1MAPT
SCHEMBL698268 0.82 TAS1R3 (0.37) ALDH1A1MEN1MAPTKMT2ATAS1R3
SCHEMBL2111601 0.80 LMNA (0.50) SMN1; SMN2NPSR1ALDH1A1MEN1MAPT
SCHEMBL699065 0.79 TAS1R3 (0.36) MEN1MAPTKMT2ATAS1R3TAS1R1
SCHEMBL2005866 0.79 SMN1; SMN2 (0.49) SMN1; SMN2NPSR1HSD17B10PTGS1KDM4E
SCHEMBL1360387 0.77 PTGS1 (0.45) SMN1; SMN2NPSR1HSD17B10PTGS1KDM4E
SCHEMBL13875600 0.75 KDM4E (0.45) SMN1; SMN2NPSR1HSD17B10PTGS1KDM4E
SCHEMBL4182215 0.75 PTGS1 (0.47) SMN1; SMN2NPSR1HSD17B10PTGS1KDM4E
SCHEMBL4178309 0.75 PTGS1 (0.45) SMN1; SMN2NPSR1HSD17B10PTGS1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2535327-A1 Insecticidal 3-acylaminobenzanilides Bayer CropScience AG (DE) 2012-12-19 EP disclosed
US-7964735-B2 Insecticidal 3-acylaminobenzanilides BAYER CROPSCIENCE AG (DE) 2011-06-21 US disclosed
US-20090215623-A1 Insecticidal 3-acylaminobenzanilides BAYER CROPSCIENCE AG (DE) 2009-08-27 US disclosed
EP-1912933-A1 INSECTICIDAL 3-ACYLAMINOBENZANILIDES Bayer CropScience AG (DE) 2008-04-23 EP disclosed
WO-2007017075-A1 INSECTICIDAL 3-ACYLAMINOBENZANILIDES BAYER CROPSCIENCE AG (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215623-A1 Insecticidal 3-acylaminobenzanilides CBR3, AADAC, DDT SMN1; SMN2 4300/4885NPSR1 1017/4885HSD17B10 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.